Previous Article | Next Article ![]()
Infection and Immunity, April 2002, p. 2215-2219, Vol. 70, No. 4
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.4.2215-2219.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Veterinary Parasitology, University of Glasgow, Glasgow G61 1QH, Scotland
Received 4 September 2001/ Returned for modification 1 November 2001/ Accepted 28 November 2001
|
|
|---|
|
|
|---|
ß T cells (double negative [DN]). The majority of
ß NK1.1+ T cells are positively selected on class I or class I-related molecules and have restricted T-cell receptor usage (14). Their restricted T-cell receptor repertoire (V
14-J
281) has led some authors to propose that they may have evolved to recognize particular antigens. In both mouse and human systems, NK T cells recognize lipid and/or glycolipid antigens, often in the context of CD1 (1-3, 11, 19). For example, the recognition by V
14+ NK T cells of the synthetic glycolipid antigen
-galactosylceramide (
-GalCer) in a CD1-restricted manner has proved to be a very useful model for characterizing these cells (5). Upon primary stimulation with
-GalCer, V
14+ NK T cells can secrete either IL-4 or gamma interferon, depending upon the antigen-presenting cell (APC) (5); however, subsequent exposure to
-GalCer or immunization with
-GalCer predisposes to the development of Th2 cells (6, 20). The ability of NK T cells to secrete large quantities of cytokines following primary stimulation suggests that they may have a role in polarizing the subsequent adaptive T-helper-cell response.
Nematode parasites are among the most potent stimulators of Th2 responses (10), and it has been postulated that prototypic Th2 agents, for example, allergens and nematode parasites, may have the ability to activate a sufficient number of NK1.1+ T cells to result in rapid cytokine production, which can subsequently promote the development of the acquired immune response (22). In a previous study we demonstrated that infection of BALB/c mice with the third-stage larvae (L3) of Brugia pahangi elicits a significant burst of IL-4 transcription from a double-negative (CD4- CD8-)
ß T cell within 24 h of infection (15). In this work we extend these observations to demonstrate that NK T cells are indeed the source of early IL-4 at 24 h postinfection (hpi) and that this response is dependent upon the presence of live L3.
Male C57BL/6 mice, 6 weeks old, were purchased from Harlan Olac (Bicester, United Kingdom) and were maintained in filter-topped cages. B. pahangi L3 were harvested from infected Aedes aegypti mosquitoes by standard methods (8), washed in sterile Hanks balanced salt solution (HBSS) (Gibco/BRL), and counted. C57BL/6 mice were injected with 50 L3 in HBSS intravenously (i.v.) or injected with 30 L3 per hind footpad.
At 24 hpi, spleen cells (from mice with i.v. infections) were processed from five individual mice. Popliteal lymph node cells (from mice with footpad infections) were pooled from five animals per group. Cell suspensions were incubated for 2 h with brefeldin A (10 µg/ml; Sigma) in RPMI medium at 37°C with 5% CO2. The cells were washed and resuspended in blocking buffer (Fc block, the supernatant from rat anti-mouse CD16/CD32 monoclonal antibody [MAb] 24G2, 10% normal mouse serum, 0.2% sodium azide in phosphate-buffered saline [PBS]). For cell surface phenotypic analysis, the appropriate MAb or isotype-matched control MAb (all from Pharmingen) was added at 1 µg per 106 cells and incubated on ice for 15 min. Antibodies used were Cy-Chrome-labeled anti-mouse CD3 (145-2c11), APC-labeled anti-mouse CD4 (RM4-5), and fluorescein isothiocyanate-labeled anti-NK1.1 (PK136). Isotype controls were Cy-Chrome-labeled hamster immunoglobulin G (IgG) (A19-3), APC-labeled rat IgG2a (R35-95), phycoerythrin-labeled rat IgG2b (R35-38), and fluorescein isothiocyanate-labeled mouse IgG2a (G155-178). Cells were washed with PBS and fixed with 4% formaldehyde in PBS at room temperature for 20 min. Following one wash with ice-cold PBS and two washes with permeabilization buffer (0.2% sodium azide, 0.1% saponin [pH 7.4 to 7.6]), the cells were resuspended in permeabilization buffer and stained with 2 µg of phycoerythrin-labeled anti-mouse IL-4 (BVD4-1D11) per 106 cells. The cells were washed twice and analyzed on a Becton Dickinson FACSCalibur using CELLQUEST software (Becton Dickinson). Viable lymphocytes were gated by forward and side light scatter, and the gates for positive staining for CD3 and NK1.1 were set by comparison with isotype control MAb. The percentage of lymphocytes coexpressing CD3 and NK1.1+ was determined from 100,000 total events per sample. For analysis of intracellular IL-4, the acquisition gate was set on CD3+ NK1.1+ cells, and the number of cells coexpressing IL-4 was determined. Differences between groups were compared using the t test, with P values below 0.05 being considered significant.
Infection of C57BL/6 mice with L3 of B. pahangi by the i.v. route resulted in a significant increase in the percentage of NK1.1+ T cells in L3-infected mice at 24 hpi, from 3.3% in control animals given HBSS i.v. to 6.7% in L3-infected animals (Fig. 1A). In six separate experiments there was a significant twofold increase in the number of lymphocytes that were CD3+ NK1.1+ in the spleen within 24 h of infection with L3 compared to that in uninfected controls given HBSS (P < 0.015). At this time point there was no difference between the total number of lymphocytes in the spleens of L3-infected mice and that in control mice.
![]() View larger version (27K): [in a new window] |
FIG. 1. NK T cells expand in response to infection with L3 of B. pahangi. Shown are representative scatter plots of CD3+ NK1.1+ lymphocytes in the spleens of C57BL/6 mice infected with 50 L3 of B. pahangi or control animals (A) or in the draining popliteal lymph nodes of mice injected with approximately 30 L3 or HBSS into the footpad (B) at 24 hpi. The cells were surface stained for CD3 and NK1.1. The data acquired were gated on viable lymphocytes as determined by forward and side scatter, and the percentage of CD3+ NK1.1+ cells was expressed. Spleen data presented are from one of six representative experiments, with each experiment containing five mice per group analyzed individually. Lymph node data are from one of four replicate experiments in which pooled cells from five mice per group were analyzed.
|
25-fold) in the numbers of NK1.1+ T cells, from a mean of 1.92 x 104 in uninfected mice to 5.12 x 105 in L3-infected mice (P < 0.002) (Table 2). |
View this table: [in a new window] |
TABLE 1. Mean numbers of NK T cells (CD3+ NK1.1+) per 105 cellsa
|
|
View this table: [in a new window] |
TABLE 2. Mean absolute numbers of NK T cells (CD3+ NK 1.1+)a
|
![]() View larger version (19K): [in a new window] |
FIG. 2. NK T cells produce IL-4 in response to L3 infection at 24 hpi. (A) Spleen cells were surface stained for CD3+ and NK1.1+, washed, fixed, and permeabilized to allow intracellular staining for IL-4. Viable lymphocytes were expressed on a dot plot of CD3 versus NK1.1 for spleen cells from L3-infected mice and control mice at 24 hpi. NK T cells (CD3+ NK1.1+) were selected, and the number of IL-4+ NK T cells was expressed. Data presented are from one of seven replicate experiments. (B) Scatter plot of the number of IL-4+ NK T cells per 105 total spleen cells. Data presented are from one representative experiment of five mice per group analyzed individually. The number of IL-4-producing NK T cells was significantly greater in L3-infected mice than in control mice (P < 0.0079).
|
![]() View larger version (21K): [in a new window] |
FIG. 3. IL-4-producing NK T cells are CD4-. Spleen cells were surface stained with CD4 and NK1.1 and then washed, fixed, and permeabilized to allow intracellular staining for IL-4. (A) Gates were set on CD4+ NK1.1+ and CD4- NK1.1- populations. CD4- NK1.1+ (B) and CD4+ NK1.1+ cells (C) were analyzed as shown in the lower panels.
|
The requirement of NK T cells for the development of a Th2 response remains controversial. Initially, NK T cells were proposed as a possible source of IL-4 that was essential for priming naïve CD4+ T cells to differentiate into Th2 effector cells (22). However, it was subsequently shown using ß2-microglobulin knockout mice, which have greatly reduced numbers of NK T cells, that normal IL-4-dominated Th2 responses can develop in the absence of NK T cells (7, 23). Furthermore, in different models of infectious disease, additional sources of IL-4 at the start of an immune response have been identified, including eosinophils (17) and non-NK CD4+ T cells (13). Presumably, the cellular source of IL-4 varies with both the antigen and the site of infection, and as with many other facets of the immune response, it is likely that other cell types can compensate in the absence of NK T cells.
The prompt production of cytokines by NK T cells in response to L3 infection will affect the differentiation of naive CD4+ T cells by influencing the cytokine microenvironment in which they are stimulated (4). The immune response in human filariasis is characterized by a Th2 bias in which even apparently uninfected individuals exposed to the bites of infected mosquitoes express elevated levels of IL-4 (reviewed in reference 9). Moreover, recent studies in humans infected with filaria have shown that under conditions of intense L3 transmission, T-cell responses are profoundly affected while levels of IL-4 in plasma are elevated (12). Antigens derived from the L3 preferentially stimulated IL-4 release from basophils compared to antigen extracts from other life cycle stages (12). Thus, exposure to the L3 of filarial worms may be an important determinant of the eventual immune response in filariasis. Defining the nature of the L3-specific antigens that elicit the early IL-4 response will be a considerable challenge for future studies.
This project was funded by a grant from the MRC.
|
|
|---|
ß+ T cells. Nature 372:691-694.[CrossRef][Medline]
8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541-549.[CrossRef][Medline]
ß+ cells: new clues to their origin, specificity and function. J. Exp. Med. 182:633-638.
ß T cell population. Int. Immunol. 10:1583-1590.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»